STB
REGN icon

S&T Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

S&T Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.99K Sell
8
-3
-27% -$2.04K ﹤0.01% 342
2026
Q1 		$8.5K Buy
11
+3
+38% +$2.3K ﹤0.01% 299
2025
Q4 		$6.17K Sell
8
-2
-20% -$1.36K ﹤0.01% 284
2025
Q3 		$5.62K Buy
10
+3
+43% +$1.7K ﹤0.01% 306
2025
Q2 		$3.67K Buy
+7
New +$3.91K ﹤0.01% 323

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

S&T Bank's REGN Position: Q2 2026 in Review

S&T Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 27% in Q2 2026, selling an estimated $2.04K and leaving 8 shares worth $4.99K. The position accounts for ﹤0.01% of the portfolio, ranked #342.

S&T Bank first reported a position in REGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.5K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • S&T Bank held 8 shares of Regeneron Pharmaceuticals worth $4.99K as of Q2 2026.
  • S&T Bank sold 3 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.04K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of S&T Bank's portfolio in Q2 2026, its #342 holding.
  • S&T Bank first reported a position in Regeneron Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • S&T Bank's Regeneron Pharmaceuticals position peaked at $8.5K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.